105 related articles for article (PubMed ID: 15121755)
1. A pilot phase II study of capecitabine in advanced or recurrent colorectal cancer.
Kondo Y; Terashima M; Sato A; Taguchi T
Jpn J Clin Oncol; 2004 Apr; 34(4):195-201. PubMed ID: 15121755
[TBL] [Abstract][Full Text] [Related]
2. A phase II Study of the global dose and schedule of capecitabine in Japanese patients with metastatic colorectal cancer.
Hyodo I; Shirao K; Doi T; Hatake K; Arai Y; Yamaguchi K; Tamura T; Takemiya S; Takiuchi H; Nakagawa K; Mishima H
Jpn J Clin Oncol; 2006 Jul; 36(7):410-7. PubMed ID: 16825251
[TBL] [Abstract][Full Text] [Related]
3. A pilot phase II study of capecitabine in advanced or recurrent breast cancer.
Saeki T; Kimura T; Toi M; Taguchi T
Breast Cancer; 2006; 13(1):49-57. PubMed ID: 16518062
[TBL] [Abstract][Full Text] [Related]
4. A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer.
Hong YS; Song SY; Lee SI; Chung HC; Choi SH; Noh SH; Park JN; Han JY; Kang JH; Lee KS; Cho JY
Ann Oncol; 2004 Sep; 15(9):1344-7. PubMed ID: 15319239
[TBL] [Abstract][Full Text] [Related]
5. A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors.
Saeki T; Takashima S; Terashima M; Satoh A; Toi M; Osaki A; Toge T; Ohno S; Nomura N; Fukuyama Y; Koizumi W; Taguchi T
Int J Clin Oncol; 2005 Feb; 10(1):51-7. PubMed ID: 15729602
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer.
Kusama M; Nomizu T; Aogi K; Yoshimoto M; Horikoshi N; Tabei T; Noguchi S; Miura S; Yoshimura N; Kimura M; Toyama K; Shin E
Breast Cancer; 2010 Oct; 17(4):233-40. PubMed ID: 19633909
[TBL] [Abstract][Full Text] [Related]
7. A phase II Japanese study of a modified capecitabine regimen for advanced or metastatic colorectal cancer.
Sakamoto J; Kondo Y; Takemiya S; Sakamoto N; Nishisho I;
Anticancer Drugs; 2004 Feb; 15(2):137-43. PubMed ID: 15075669
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of a 4-week capecitabine regimen in advanced or recurrent gastric cancer.
Sakamoto J; Chin K; Kondo K; Kojima H; Terashima M; Yamamura Y; Tsujinaka T; Hyodo I; Koizumi W;
Anticancer Drugs; 2006 Feb; 17(2):231-6. PubMed ID: 16428943
[TBL] [Abstract][Full Text] [Related]
9. Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: a Korean Cancer Study Group trial.
Kim TW; Kang WK; Chang HM; Park JO; Ryoo BY; Ahn JS; Zang DY; Lee KH; Kang YK; Kim SR; Kim HK;
Acta Oncol; 2005; 44(3):230-5. PubMed ID: 16076694
[TBL] [Abstract][Full Text] [Related]
10. A pilot phase II study of capecitabine in advanced or recurrent gastric cancer.
Koizumi W; Saigenji K; Ujiie S; Terashima M; Sakata Y; Taguchi T;
Oncology; 2003; 64(3):232-6. PubMed ID: 12697963
[TBL] [Abstract][Full Text] [Related]
11. Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy.
Lee JJ; Kim TM; Yu SJ; Kim DW; Joh YH; Oh DY; Kwon JH; Kim TY; Heo DS; Bang YJ; Kim NK
Jpn J Clin Oncol; 2004 Jul; 34(7):400-4. PubMed ID: 15342667
[TBL] [Abstract][Full Text] [Related]
12. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.
Van Cutsem E; Twelves C; Cassidy J; Allman D; Bajetta E; Boyer M; Bugat R; Findlay M; Frings S; Jahn M; McKendrick J; Osterwalder B; Perez-Manga G; Rosso R; Rougier P; Schmiegel WH; Seitz JF; Thompson P; Vieitez JM; Weitzel C; Harper P;
J Clin Oncol; 2001 Nov; 19(21):4097-106. PubMed ID: 11689577
[TBL] [Abstract][Full Text] [Related]
13. Capecitabine: a review.
Walko CM; Lindley C
Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer.
Gajria D; Gonzalez J; Feigin K; Patil S; Chen C; Theodoulou M; Drullinsky P; D'Andrea G; Lake D; Norton L; Hudis CA; Traina TA
Breast Cancer Res Treat; 2012 Jan; 131(1):111-6. PubMed ID: 21898114
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study.
Akgun Z; Saglam S; Yucel S; Gural Z; Balik E; Cipe G; Yildiz S; Kilickap S; Okyar A; Kaytan-Saglam E
Cancer Chemother Pharmacol; 2014 Oct; 74(4):751-6. PubMed ID: 25102935
[TBL] [Abstract][Full Text] [Related]
16. Five-day continuous infusion of 5-fluorouracil and pulsed folinic acid in patients with metastatic colorectal carcinoma: an effective second-line regimen.
Streit M; Jaehde U; Stremetzne S; Ridwelski K; Kerz H; Strohbach F; Hohenberger P; Zwiebel FM; Hebart H; Böthig R; Kairies M; Zillig D; Schuchmann S; Warnecke S; Thiel E; Kreuser ED
Ann Oncol; 1997 Nov; 8(11):163-5. PubMed ID: 9426339
[TBL] [Abstract][Full Text] [Related]
17. The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been?
Glynne-Jones R; Dunst J; Sebag-Montefiore D
Ann Oncol; 2006 Mar; 17(3):361-71. PubMed ID: 16500912
[TBL] [Abstract][Full Text] [Related]
18. [Oral capecitabine as postoperative adjuvant chemotherapy in stage III colon cancer patients].
Yamaguchi T; Fukuda M; Yasui H; Okazaki S; Kubo K; Tanaka M; Une Y; Setoguchi Y; Hanada K; Moriyama S; Tani M; Murakami T; Okuchi Y; Ogiso S; Hata H; Sakata S; Otani T; Yamato T; Ikai I
Gan To Kagaku Ryoho; 2012 Mar; 39(3):389-93. PubMed ID: 22421765
[TBL] [Abstract][Full Text] [Related]
19. Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study.
Feliu J; Escudero P; Llosa F; Bolaños M; Vicent JM; Yubero A; Sanz-Lacalle JJ; Lopez R; Lopez-Gómez L; Casado E; Gómez-Reina MJ; González-Baron M
J Clin Oncol; 2005 May; 23(13):3104-11. PubMed ID: 15860870
[TBL] [Abstract][Full Text] [Related]
20. Capecitabine: a review of its pharmacology and therapeutic efficacy in the management of advanced breast cancer.
Wagstaff AJ; Ibbotson T; Goa KL
Drugs; 2003; 63(2):217-36. PubMed ID: 12515569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
